Insider Transactions in Q3 2023 at Boston Scientific Corp (BSX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
15,867
-7.42%
|
$872,685
$55.0 P/Share
|
|
Sep 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-16.98%
|
$618,563
$53.95 P/Share
|
|
Sep 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+4.56%
|
$89,712
$14.7 P/Share
|
|
Sep 12
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
113,355
-7.03%
|
$6,007,815
$53.91 P/Share
|
|
Sep 12
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
113,355
+3.46%
|
$1,586,970
$14.7 P/Share
|
|
Aug 31
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Bona fide gift
|
Indirect |
1,095
+0.62%
|
-
|
|
Aug 30
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Bona fide gift
|
Indirect |
141,450
+44.68%
|
-
|
|
Aug 30
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Bona fide gift
|
Direct |
318,218
-17.51%
|
-
|
|
Aug 29
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
4,657
-7.14%
|
$251,478
$54.5 P/Share
|
|
Aug 28
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
13,971
-17.64%
|
$740,463
$53.14 P/Share
|
|
Aug 25
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Open market or private sale
|
Direct |
15,750
-35.53%
|
$787,500
$50.52 P/Share
|
|
Aug 21
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
6,600
-36.67%
|
$330,000
$50.4 P/Share
|
|
Aug 18
2023
|
Charles J Dockendorff Director |
SELL
Open market or private sale
|
Direct |
17,079
-81.23%
|
$853,950
$50.74 P/Share
|
|
Aug 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-15.77%
|
$595,221
$51.3 P/Share
|
|
Aug 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+4.24%
|
$89,712
$14.7 P/Share
|
|
Aug 02
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
487
-1.34%
|
$24,350
$50.62 P/Share
|
|
Aug 02
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,090
+2.91%
|
-
|
|
Jul 17
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-14.73%
|
$606,892
$52.85 P/Share
|
|
Jul 17
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+3.96%
|
$89,712
$14.7 P/Share
|
|
Jul 03
2023
|
Jessica L Mega Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,253
+50.0%
|
-
|
|
Jul 03
2023
|
Susan E Morano Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,082
+33.98%
|
-
|
|
Jul 01
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,359
-2.97%
|
$73,386
$54.09 P/Share
|
|
Jul 01
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,036
+8.12%
|
-
|
|
Jul 01
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
326
-0.92%
|
$17,604
$54.09 P/Share
|
|
Jul 01
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
729
+2.01%
|
-
|